Disproportionally Impaired Diffusion Capacity Relative to Airflow Limitation in COPD.

COPD
Naoya TanabeToyohiro Hirai

Abstract

Forced expiratory volume in 1 s (FEV1) is a standard physiological index of chronic obstructive pulmonary disease (COPD), but reflects emphysema and vascular abnormalities less sensitively than diffusion capacity for carbon monoxide (DLCO). This study tested whether a disproportionally impaired DLCO relative to FEV1 (FEV1 z-score>-3 and DLCO z-score≤-3) is a common functional COPD phenotype associated with distinct clinical and structural features and the prognosis of two cohorts. The cross-sectional analyses of the Korea COPD Subgroup Study (KOCOSS) cohort (multicenter study in Korea) included 743 males with COPD whose DLCO was available. The cross-sectional and longitudinal analyses of the Kyoto University Cohort (single-center study in Japan) included 195 males with COPD who were prospectively followed for 10 years. A disproportionally impaired DLCO relative to FEV1 was observed in 29% and 31% of patients in the KOCOSS and Kyoto University cohorts, respectively. In the multivariable analysis, the disproportionally impaired DLCO was associated with worse symptoms, shorter 6-minute walking distance, paraseptal and centrilobular emphysema on computed tomography, and reduced arterial oxygen and carbon dioxide pressures compared ...Continue Reading

References

Jun 1, 1992·The American Review of Respiratory Disease·P W JonesP Littlejohns
Jan 1, 1990·The American Review of Respiratory Disease·N J MorrisonK G Evans
Jul 1, 1996·American Journal of Respiratory and Critical Care Medicine·P A GevenoisJ C Yernault
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·Y NakanoM Mishima
Oct 6, 2005·The European Respiratory Journal·N MacintyreJ Wanger
Oct 31, 2009·American Journal of Respiratory and Critical Care Medicine·Shin MatsuokaUNKNOWN National Emphysema Treatment Trial Research Group
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Naoya TanabeMichiaki Mishima
May 14, 2011·The European Respiratory Journal·F A A Mohamed HoeseinJ-W J Lammers
Jun 30, 2012·The European Respiratory Journal·Philip H QuanjerUNKNOWN ERS Global Lung Function Initiative
Sep 4, 2012·The New England Journal of Medicine·J Michael WellsUNKNOWN ECLIPSE Study Investigators
Jan 26, 2013·The European Respiratory Journal·Afroditi K BoutouNicholas S Hopkinson
Mar 23, 2013·The European Respiratory Journal·Philip H QuanjerJeffrey J Pretto
May 10, 2013·American Journal of Respiratory and Critical Care Medicine·Raúl San José EstéparUNKNOWN COPDGene Study
Aug 31, 2013·The European Respiratory Journal·Philip H QuanjerPiotr W Boros
Jan 5, 2014·The American Journal of Medicine·Benjamin M SmithR Graham Barr
Jul 8, 2014·Respiratory Investigation·Masaru KubotaUNKNOWN Clinical Pulmonary Functions Committee of the Japanese Respiratory Society
Jun 13, 2015·American Journal of Respiratory and Critical Care Medicine·Katja HueperR Graham Barr
Sep 1, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Chin Kook RheeHyoung Kyu Yoon
Nov 7, 2015·The European Respiratory Journal·Ben-Gary HarveyRonald G Crystal
Jan 13, 2016·Journal of Global Health·Davies AdeloyeUNKNOWN Global Health Epidemiology Reference Group (GHERG)
Oct 27, 2016·Respiration; International Review of Thoracic Diseases·Pierachille SantusMauro Carone
Sep 13, 2017·The European Respiratory Journal·Sanja StanojevicUNKNOWN Global Lung Function Initiative (GLI) TLCO
Sep 20, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kiyoshi UemasuToyohiro Hirai
Nov 6, 2018·Respiratory Investigation·Naoya TanabeToyohiro Hirai
Jul 10, 2019·Chest·Jinkyeong ParkUNKNOWN COPDGene Investigators
Jul 29, 2019·Chest·Aparna BalasubramanianMeredith C McCormack
Jan 11, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Joon Young ChoiChin Kook Rhee
Jun 3, 2020·American Journal of Respiratory and Critical Care Medicine·Naoya TanabeJames C Hogg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.